CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: phenol red
Accession: CHEBI:31991
browse the term
Definition: 3H-2,1-Benzoxathiole 1,1-dioxide in which both of the hydrogens at position 3 have been substituted by 4-hydroxyphenyl groups. A pH indicator changing colour from yellow below pH 6.8 to bright pink above pH 8.2, it is commonly used as an indicator in cell cultures and in home swimming pool test kits. It is also used in the (now infrequently performed) phenolsulfonphthalein (PSP) test for estimation of overall blood flow through the kidney.
Synonyms: exact_synonym: 4,4'-(1,1-dioxido-3H-2,1-benzoxathiole-3,3-diyl)diphenol
related_synonym: 3,3-bis(p-hydroxyphenyl)-3H-2,1-benzoxathiole 1,1-dioxide; 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bisphenol S,S-dioxide; Formula=C19H14O5S; InChI=1S/C19H14O5S/c20-15-9-5-13(6-10-15)19(14-7-11-16(21)12-8-14)17-3-1-2-4-18(17)25(22,23)24-19/h1-12,20-21H; InChIKey=BELBBZDIHDAJOR-UHFFFAOYSA-N; PSP; Phenolsulfonphthalein; SMILES=Oc1ccc(cc1)C1(OS(=O)(=O)c2ccccc12)c1ccc(O)cc1; alpha-hydroxy-alpha,alpha-bis(p-hydroxyphenyl)-o-toluenesulfonic acid gamma-sultone
xref: Beilstein:326470; CAS:143-74-8; Drug_Central:3439; KEGG:C12600; KEGG:D01200
xref_mesh: MESH:D010637
G
ABCC2
ATP binding cassette subfamily C member 2
affects export
ISO
ABCC2 protein affects the export of Phenolsulfonphthalein
CTD
PMID:15618741
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
G
ACTBL2
actin beta like 2
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of ACTBL2 protein
CTD
PMID:31629898
NCBI chr 5:57,480,018...57,482,811
Ensembl chr 5:57,480,018...57,482,811
G
AFAP1
actin filament associated protein 1
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of AFAP1 protein
CTD
PMID:31629898
NCBI chr 4:7,758,713...7,939,861
Ensembl chr 4:7,758,714...7,939,926
G
AKT1
AKT serine/threonine kinase 1
multiple interactions
EXP
Phenolsulfonphthalein results in decreased phosphorylation of and results in decreased activity of AKT1 protein
CTD
PMID:17203231
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
G
ANKRD17
ankyrin repeat domain 17
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of ANKRD17 protein
CTD
PMID:31629898
NCBI chr 4:73,073,376...73,258,798
Ensembl chr 4:73,073,376...73,258,798
G
ANXA11
annexin A11
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of ANXA11 protein
CTD
PMID:31629898
NCBI chr10:80,150,889...80,205,808
Ensembl chr10:80,150,889...80,205,572
G
ANXA3
annexin A3
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of ANXA3 protein
CTD
PMID:31629898
NCBI chr 4:78,551,770...78,610,447
Ensembl chr 4:78,551,747...78,610,451
G
ARCN1
archain 1
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of ARCN1 protein
CTD
PMID:31629898
NCBI chr11:118,572,409...118,603,033
Ensembl chr11:118,572,390...118,603,033
G
ASAP1
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of ASAP1 protein
CTD
PMID:31629898
NCBI chr 8:130,052,104...130,443,674
Ensembl chr 8:130,052,104...130,443,674
G
BCL2L1
BCL2 like 1
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of BCL2L1 protein
CTD
PMID:31629898
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
G
CDH1
cadherin 1
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of CDH1 protein; [Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in decreased expression of CDH1 protein
CTD
PMID:31629898
NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
G
CDH2
cadherin 2
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of CDH2 protein
CTD
PMID:31629898
NCBI chr18:27,932,879...28,177,130
Ensembl chr18:27,932,879...28,177,946
G
CFL2
cofilin 2
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of CFL2 protein
CTD
PMID:31629898
NCBI chr14:34,709,113...34,714,593
Ensembl chr14:34,709,113...34,714,823
G
CKAP5
cytoskeleton associated protein 5
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of CKAP5 protein
CTD
PMID:31629898
NCBI chr11:46,743,048...46,846,280
Ensembl chr11:46,743,048...46,846,308
G
CTCF
CCCTC-binding factor
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of CTCF protein
CTD
PMID:31629898
NCBI chr16:67,562,526...67,639,185
Ensembl chr16:67,562,467...67,639,177
G
CTNNB1
catenin beta 1
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of CTNNB1 protein
CTD
PMID:31629898
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
G
CTNNBL1
catenin beta like 1
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of CTNNBL1 protein
CTD
PMID:31629898
NCBI chr20:37,694,030...37,872,118
Ensembl chr20:37,694,030...37,872,129
G
CTNND1
catenin delta 1
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of CTNND1 protein
CTD
PMID:31629898
NCBI chr11:57,761,802...57,819,540
Ensembl chr11:57,753,243...57,819,546
G
DNM1
dynamin 1
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of DNM1 protein
CTD
PMID:31629898
NCBI chr 9:128,203,379...128,255,244
Ensembl chr 9:128,191,655...128,255,248
G
DNM2
dynamin 2
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of DNM2 protein
CTD
PMID:31629898
NCBI chr19:10,718,079...10,831,903
Ensembl chr19:10,718,055...10,833,488
G
DSG2
desmoglein 2
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of DSG2 protein
CTD
PMID:31629898
NCBI chr18:31,498,177...31,549,008
Ensembl chr18:31,498,177...31,549,008
G
DYNC1LI1
dynein cytoplasmic 1 light intermediate chain 1
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of DYNC1LI1 protein
CTD
PMID:31629898
NCBI chr 3:32,525,974...32,570,858
Ensembl chr 3:32,525,974...32,570,858
G
DYNLT1
dynein light chain Tctex-type 1
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of DYNLT1 protein
CTD
PMID:31629898
NCBI chr 6:158,636,474...158,644,743
Ensembl chr 6:158,636,474...158,644,743
G
EIF2B4
eukaryotic translation initiation factor 2B subunit delta
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of EIF2B4 protein
CTD
PMID:31629898
NCBI chr 2:27,364,352...27,370,338
Ensembl chr 2:27,364,352...27,370,338
G
EIF4A3
eukaryotic translation initiation factor 4A3
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of EIF4A3 protein
CTD
PMID:31629898
NCBI chr17:80,134,369...80,147,128
Ensembl chr17:80,134,369...80,147,151
G
ESRRG
estrogen related receptor gamma
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] inhibits the reaction [ESRRG protein binds to GJA1 protein binds to SNAI1 protein]; [Phenolsulfonphthalein deficiency co-treated with bisphenol A] inhibits the reaction [ESRRG protein binds to GJA1 protein binds to SNAI1 protein]; [Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of ESRRG protein
CTD
PMID:31629898
NCBI chr 1:216,503,246...217,137,702
Ensembl chr 1:216,503,246...217,137,755
G
G3BP1
G3BP stress granule assembly factor 1
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of G3BP1 protein
CTD
PMID:31629898
NCBI chr 5:151,771,954...151,812,785
Ensembl chr 5:151,771,045...151,812,911
G
GDI2
GDP dissociation inhibitor 2
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of GDI2 protein
CTD
PMID:31629898
NCBI chr10:5,765,223...5,813,434
Ensembl chr10:5,765,223...5,842,132
G
GJA1
gap junction protein alpha 1
multiple interactions
EXP
[Phenolsulfonphthalein co-treated with bisphenol A deficiency] results in increased expression of GJA1 protein; [Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] inhibits the reaction [ESRRG protein binds to GJA1 protein binds to SNAI1 protein]; [Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in decreased expression of GJA1 protein; [Phenolsulfonphthalein deficiency co-treated with bisphenol A] inhibits the reaction [ESRRG protein binds to GJA1 protein binds to SNAI1 protein]; [Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of GJA1 protein
CTD
PMID:31629898
NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727
G
GNA13
G protein subunit alpha 13
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of GNA13 protein
CTD
PMID:31629898
NCBI chr17:65,009,289...65,056,740
Ensembl chr17:65,009,289...65,056,740
G
GNAI1
G protein subunit alpha i1
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of GNAI1 protein
CTD
PMID:31629898
NCBI chr 7:80,134,831...80,226,181
Ensembl chr 7:79,768,028...80,226,181
G
H2AC12
H2A clustered histone 12
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of H2AC12 protein
CTD
PMID:31629898
NCBI chr 6:27,147,106...27,147,562
Ensembl chr 6:27,147,106...27,147,562
G
IQGAP2
IQ motif containing GTPase activating protein 2
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of IQGAP2 protein
CTD
PMID:31629898
NCBI chr 5:76,403,285...76,708,132
Ensembl chr 5:76,403,285...76,708,132
G
KIF5B
kinesin family member 5B
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of KIF5B protein
CTD
PMID:31629898
NCBI chr10:32,009,015...32,056,425
Ensembl chr10:32,009,015...32,056,425
G
KPNA3
karyopherin subunit alpha 3
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of KPNA3 protein
CTD
PMID:31629898
NCBI chr13:49,699,320...49,792,682
Ensembl chr13:49,699,320...49,792,682
G
KRT31
keratin 31
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of KRT31 protein
CTD
PMID:31629898
NCBI chr17:41,393,721...41,397,608
Ensembl chr17:41,393,721...41,397,608
G
KRT34
keratin 34
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of KRT34 protein
CTD
PMID:31629898
NCBI chr17:41,377,669...41,383,816
Ensembl chr17:41,377,669...41,382,306
G
KRT84
keratin 84
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of KRT84 protein
CTD
PMID:31629898
NCBI chr12:52,377,812...52,386,977
Ensembl chr12:52,377,812...52,385,652
G
LSG1
large 60S subunit nuclear export GTPase 1
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of LSG1 protein
CTD
PMID:31629898
NCBI chr 3:194,640,791...194,672,191
Ensembl chr 3:194,640,791...194,672,463
G
MPO
myeloperoxidase
increases oxidation multiple interactions
EXP
MPO protein results in increased oxidation of Phenolsulfonphthalein [MPO protein results in increased oxidation of Phenolsulfonphthalein] which results in decreased abundance of Glutathione; [MPO protein results in increased oxidation of Phenolsulfonphthalein] which results in increased abundance of Glutathione Disulfide; MPO protein promotes the reaction [Phenolsulfonphthalein binds to Halogens]; Phenolsulfonphthalein promotes the reaction [MPO protein promotes the reaction [chlorodimedone binds to Chlorine]]
CTD
PMID:31288001
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
G
MYH1
myosin heavy chain 1
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of MYH1 protein
CTD
PMID:31629898
NCBI chr17:10,492,307...10,518,542
Ensembl chr17:10,492,307...10,518,542
G
MYO10
myosin X
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of MYO10 protein
CTD
PMID:31629898
NCBI chr 5:16,661,907...16,936,288
Ensembl chr 5:16,661,907...16,936,288
G
MYO5C
myosin VC
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of MYO5C protein
CTD
PMID:31629898
NCBI chr15:52,192,322...52,295,804
Ensembl chr15:52,192,322...52,295,804
G
NEMF
nuclear export mediator factor
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of NEMF protein
CTD
PMID:31629898
NCBI chr14:49,782,083...49,852,788
Ensembl chr14:49,782,083...49,852,821
G
NFIB
nuclear factor I B
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of NFIB protein
CTD
PMID:31629898
NCBI chr 9:14,081,843...14,532,077
Ensembl chr 9:14,081,843...14,398,983
G
NIFK
nucleolar protein interacting with the FHA domain of MKI67
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of NIFK protein
CTD
PMID:31629898
NCBI chr 2:121,726,945...121,736,875
Ensembl chr 2:121,726,945...121,736,911
G
NOC3L
NOC3 like DNA replication regulator
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of NOC3L protein
CTD
PMID:31629898
NCBI chr10:94,314,907...94,362,939
Ensembl chr10:94,333,226...94,362,959
G
PCBP1
poly(rC) binding protein 1
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of PCBP1 protein
CTD
PMID:31629898
NCBI chr 2:70,087,477...70,089,203
Ensembl chr 2:70,087,477...70,089,203
G
PGR
progesterone receptor
increases expression
EXP
Phenolsulfonphthalein results in increased expression of PGR protein
CTD
PMID:3458212
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
G
PHF14
PHD finger protein 14
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of PHF14 protein
CTD
PMID:31629898
NCBI chr 7:10,973,872...11,169,618
Ensembl chr 7:10,973,336...11,169,623
G
PHF5A
PHD finger protein 5A
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of PHF5A protein
CTD
PMID:31629898
NCBI chr22:41,459,717...41,468,692
Ensembl chr22:41,459,717...41,468,692
G
POU5F1
POU class 5 homeobox 1
increases expression
EXP
Phenolsulfonphthalein results in increased expression of POU5F1 mRNA
CTD
PMID:22132214
NCBI chr 6:31,164,337...31,170,682
Ensembl chr 6:31,164,337...31,180,731
G
RAB12
RAB12, member RAS oncogene family
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of RAB12 protein
CTD
PMID:31629898
NCBI chr18:8,609,437...8,639,383
Ensembl chr18:8,609,437...8,639,383
G
RAB14
RAB14, member RAS oncogene family
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of RAB14 protein
CTD
PMID:31629898
NCBI chr 9:121,178,133...121,201,869
Ensembl chr 9:121,178,133...121,223,014
G
RAB24
RAB24, member RAS oncogene family
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of RAB24 protein
CTD
PMID:31629898
NCBI chr 5:177,301,198...177,303,719
Ensembl chr 5:177,301,198...177,303,744
G
RAB27A
RAB27A, member RAS oncogene family
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of RAB27A protein
CTD
PMID:31629898
NCBI chr15:55,202,966...55,289,813
Ensembl chr15:55,202,966...55,319,113
G
RAB27B
RAB27B, member RAS oncogene family
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of RAB27B protein
CTD
PMID:31629898
NCBI chr18:54,717,857...54,895,516
Ensembl chr18:54,717,860...54,895,516
G
RAB5C
RAB5C, member RAS oncogene family
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of RAB5C protein
CTD
PMID:31629898
NCBI chr17:42,124,979...42,154,989
Ensembl chr17:42,124,978...42,155,044
G
RALA
RAS like proto-oncogene A
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of RALA protein
CTD
PMID:31629898
NCBI chr 7:39,623,572...39,708,120
Ensembl chr 7:39,623,565...39,708,120
G
RALB
RAS like proto-oncogene B
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of RALB protein
CTD
PMID:31629898
NCBI chr 2:120,240,070...120,294,710
Ensembl chr 2:120,240,064...120,294,710
G
RAP2B
RAP2B, member of RAS oncogene family
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of RAP2B protein
CTD
PMID:31629898
NCBI chr 3:153,162,226...153,170,627
Ensembl chr 3:153,162,226...153,170,627
G
RASIP1
Ras interacting protein 1
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of RASIP1 protein
CTD
PMID:31629898
NCBI chr19:48,720,585...48,740,610
Ensembl chr19:48,720,585...48,740,610
G
RMDN3
regulator of microtubule dynamics 3
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of RMDN3 protein
CTD
PMID:31629898
NCBI chr15:40,735,887...40,755,254
Ensembl chr15:40,735,884...40,755,851
G
RRAS
RAS related
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of RRAS protein
CTD
PMID:31629898
NCBI chr19:49,635,292...49,640,143
Ensembl chr19:49,635,292...49,640,143
G
RRP9
ribosomal RNA processing 9, U3 small nucleolar RNA binding protein
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of RRP9 protein
CTD
PMID:31629898
NCBI chr 3:51,933,429...51,941,904
Ensembl chr 3:51,933,429...51,941,904
G
SCAMP3
secretory carrier membrane protein 3
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of SCAMP3 protein
CTD
PMID:31629898
NCBI chr 1:155,255,981...155,262,360
Ensembl chr 1:155,255,979...155,262,430
G
SNAI1
snail family transcriptional repressor 1
multiple interactions
EXP
[Phenolsulfonphthalein co-treated with bisphenol A deficiency] results in increased expression of SNAI1 protein; [Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] inhibits the reaction [ESRRG protein binds to GJA1 protein binds to SNAI1 protein]; [Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in decreased expression of SNAI1 protein; [Phenolsulfonphthalein deficiency co-treated with bisphenol A] inhibits the reaction [ESRRG protein binds to GJA1 protein binds to SNAI1 protein]; [Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of SNAI1 protein
CTD
PMID:31629898
NCBI chr20:49,982,980...49,988,886
Ensembl chr20:49,982,980...49,988,886
G
SRP14
signal recognition particle 14
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of SRP14 protein
CTD
PMID:31629898
NCBI chr15:40,035,690...40,039,202
Ensembl chr15:40,035,690...40,039,181
G
SSBP1
single stranded DNA binding protein 1
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of SSBP1 protein
CTD
PMID:31629898
NCBI chr 7:141,738,321...141,750,488
Ensembl chr 7:141,738,334...141,787,922
G
TBXA2R
thromboxane A2 receptor
multiple interactions
ISO
Phenolsulfonphthalein inhibits the reaction [Oleic Acid results in increased expression of TBXA2R mRNA]
CTD
PMID:11263294
NCBI chr19:3,594,507...3,606,875
Ensembl chr19:3,594,507...3,606,875
G
TLN1
talin 1
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of TLN1 protein
CTD
PMID:31629898
NCBI chr 9:35,696,948...35,732,195
Ensembl chr 9:35,696,948...35,732,195
G
TUBA1A
tubulin alpha 1a
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of TUBA1A protein
CTD
PMID:31629898
NCBI chr12:49,184,795...49,189,080
Ensembl chr12:49,184,686...49,189,080
G
TUBB3
tubulin beta 3 class III
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of TUBB3 protein
CTD
PMID:31629898
NCBI chr16:89,921,925...89,936,097
Ensembl chr16:89,921,392...89,938,761
G
UGT2B15
UDP glucuronosyltransferase family 2 member B15
increases glucuronidation
EXP
UGT2B15 protein results in increased glucuronidation of Phenolsulfonphthalein
CTD
PMID:8399210
NCBI chr 4:68,646,597...68,670,652
Ensembl chr 4:68,646,597...68,670,652
G
UTP3
UTP3 small subunit processome component
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of UTP3 protein
CTD
PMID:31629898
NCBI chr 4:70,688,532...70,690,551
Ensembl chr 4:70,688,532...70,690,551
G
UTP6
UTP6 small subunit processome component
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of UTP6 protein
CTD
PMID:31629898
NCBI chr17:31,860,904...31,901,708
Ensembl chr17:31,860,904...31,901,708
G
VIM
vimentin
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of VIM protein
CTD
PMID:31629898
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
G
YBX3
Y-box binding protein 3
multiple interactions
EXP
[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of YBX3 protein
CTD
PMID:31629898
NCBI chr12:10,699,089...10,723,323
Ensembl chr12:10,699,089...10,723,323
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all